BACKGROUND: Type 1 diabetes mellitus in children may be associated with neurocognitive deficits of unclear cause. A recent retrospective study in children suggested possible associations between diabetic ketoacidosis (DKA) and decreased memory. The current investigation was undertaken to determine whether cognitive deficits could be detected after a single episode of DKA in an animal model. METHODS: Streptozotocin was used to induce diabetes in juvenile rats, and rats were then treated with subcutaneous insulin injections. In one group, insulin was subsequently withdrawn to allow development of DKA, which was then treated with insulin and saline. After recovery from DKA, subcutaneous insulin injections were re-started. In the diabetes control group, rats continued to receive subcutaneous insulin and underwent sham procedures identical to the DKA group. One week after recovery, cognitive function was tested using the Morris Water Maze, a procedure that requires rats to locate a hidden platform in a water pool using visual cues. During a 10 day period, mean time to locate the platform (latency) during 4 trials per day was recorded. RESULTS: Comparison of latency curves demonstrated longer mean latency times on days 7 and 8 in the DKA group indicating delayed learning compared to diabetic controls. CONCLUSIONS: These data demonstrate that a single DKA episode results in measurable deficits in learning in rats, consistent with findings that DKA may contribute to neurocognitive deficits in children with type 1 diabetes.
BACKGROUND:Type 1 diabetes mellitus in children may be associated with neurocognitive deficits of unclear cause. A recent retrospective study in children suggested possible associations between diabetic ketoacidosis (DKA) and decreased memory. The current investigation was undertaken to determine whether cognitive deficits could be detected after a single episode of DKA in an animal model. METHODS:Streptozotocin was used to induce diabetes in juvenile rats, and rats were then treated with subcutaneous insulin injections. In one group, insulin was subsequently withdrawn to allow development of DKA, which was then treated with insulin and saline. After recovery from DKA, subcutaneous insulin injections were re-started. In the diabetes control group, rats continued to receive subcutaneous insulin and underwent sham procedures identical to the DKA group. One week after recovery, cognitive function was tested using the Morris Water Maze, a procedure that requires rats to locate a hidden platform in a water pool using visual cues. During a 10 day period, mean time to locate the platform (latency) during 4 trials per day was recorded. RESULTS: Comparison of latency curves demonstrated longer mean latency times on days 7 and 8 in the DKA group indicating delayed learning compared to diabetic controls. CONCLUSIONS: These data demonstrate that a single DKA episode results in measurable deficits in learning in rats, consistent with findings that DKA may contribute to neurocognitive deficits in children with type 1 diabetes.
Authors: Anna Maria Patiño-Fernández; Alan M Delamater; E Brooks Applegate; Erika Brady; Margaret Eidson; Robin Nemery; Luis Gonzalez-Mendoza; Samuel Richton Journal: Pediatr Diabetes Date: 2010-04-23 Impact factor: 4.866
Authors: Nicole S Glaser; Sandra L Wootton-Gorges; Michael H Buonocore; James P Marcin; Arleta Rewers; John Strain; Joseph DiCarlo; E Kirk Neely; Patrick Barnes; Nathan Kuppermann Journal: Pediatr Diabetes Date: 2006-04 Impact factor: 4.866
Authors: Tamara Hershey; Dana C Perantie; Stacie L Warren; Emily C Zimmerman; Michelle Sadler; Neil H White Journal: Diabetes Care Date: 2005-10 Impact factor: 19.112
Authors: Andrew P Yonelinas; Neal E A Kroll; Joel R Quamme; Michele M Lazzara; Mary-Jane Sauvé; Keith F Widaman; Robert T Knight Journal: Nat Neurosci Date: 2002-11 Impact factor: 24.884
Authors: N Glaser; P Barnett; I McCaslin; D Nelson; J Trainor; J Louie; F Kaufman; K Quayle; M Roback; R Malley; N Kuppermann Journal: N Engl J Med Date: 2001-01-25 Impact factor: 91.245
Authors: E B Isaacs; F Vargha-Khadem; K E Watkins; A Lucas; M Mishkin; D G Gadian Journal: Proc Natl Acad Sci U S A Date: 2003-10-10 Impact factor: 11.205
Authors: Nicole S Glaser; Sandra L Wootton-Gorges; James P Marcin; Michael H Buonocore; Joseph Dicarlo; E Kirk Neely; Patrick Barnes; Jenny Bottomly; Nathan Kuppermann Journal: J Pediatr Date: 2004-08 Impact factor: 4.406
Authors: Thomas M Hallam; Candace L Floyd; Michael M Folkerts; Lillian L Lee; Q-Z Gong; Bruce G Lyeth; J Paul Muizelaar; Robert F Berman Journal: J Neurotrauma Date: 2004-05 Impact factor: 5.269
Authors: Sholeen T Nett; Janelle A Noble; Daniel L Levin; Natalie Z Cvijanovich; Monica S Vavilala; J Dean Jarvis; Heidi R Flori Journal: J Pediatr Intensive Care Date: 2014
Authors: Fergus J Cameron; Shannon E Scratch; Caroline Nadebaum; Elisabeth A Northam; Ildiko Koves; Juliet Jennings; Kristina Finney; Jeffrey J Neil; R Mark Wellard; Mark Mackay; Terrie E Inder Journal: Diabetes Care Date: 2014-06 Impact factor: 19.112
Authors: Nicole Glaser; Steven Chu; Benjamin Hung; Luis Fernandez; Heike Wulff; Daniel Tancredi; Martha E ODonnell Journal: BMJ Open Diabetes Res Care Date: 2020-12